0
NovaBridge Biosciences Banner Image

NovaBridge Biosciences has reached its limit for free report views

Work for NovaBridge Biosciences? Upgrade Your Profile and unlock all your responsibility reports.

NovaBridge Biosciences

  • Ticker IMAB
    NBP
    Exchange NASDAQ More
    NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
NovaBridge Biosciences Logo Image
  • 11-50 Employees
  • Based in Rockville, Maryland
NovaBridge Biosciences (Nasdaq: NBP) is a global biotechnology company advancing a portfolio of therapeutic programs in oncology and ophthalmology. The Company identifies differentiated therapeutic opportunities, generates value-defining clinical evidence, and applies the development, financing, and partnering strategy best suited to each program. NovaBridge’s portfolio is led by givastomigMore and VIS-101. The Company's objective is to build a sustainable biotechnology company by repeatedly identifying differentiated innovation, advancing it efficiently, and bringing novel therapies to patients through the path best suited to each opportunity.
NovaBridge Biosciences

Most Recent Responsibility Report

NovaBridge Biosciences
MOST RECENT 2021 Environmental, Social & Governance Report

Report Locked. NovaBridge Biosciences has reached its limit for free report views.

NovaBridge Biosciences does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived NovaBridge Biosciences Sustainability Report, NovaBridge Biosciences Corporate Social Responsibility Report, NovaBridge Biosciences CSR Report, NovaBridge Biosciences Corporate Responsibility, NovaBridge Biosciences CR Report, NovaBridge Biosciences Citizenship Report, NovaBridge Biosciences ESG Report, and NovaBridge Biosciences Environmental Report online.
NovaBridge Biosciences Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!